Leading the way to safer medication
 Crosscheck  Recommender

Therapeutic Indications

Cetrorelix is indicated for:

Prevention of premature ovulation

Women only, only Adults (18 - 65 years old)

Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Subcutaneous - 0.25 mg once daily

Contraindications

Active ingredient Cetrorelix is contraindicated in the following cases:

Severe renal impairment

No gender/age discrimination

Lactation

No gender/age discrimination

Cetrorelix is not intended to be used during lactation.

Pregnancy

No gender/age discrimination

Cetrorelix is not intended to be used during pregnancy.